Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Intrathecal Pain Pump topic
No spam. Unsubscribe anytime.
Committee advances bill to extend intrathecal pump refill interval from 90 to 180 days
Summary
House Bill 1200 would allow certain implanted intrathecal drug pumps to be refilled every six months instead of every 90 days. Sponsor and an interventional pain specialist said longer intervals reduce patient burden and risks associated with frequent visits; committee voted 12–0 to pass the measure.
House Bill 1200 would change the required refill schedule for implanted intrathecal drug pumps, moving from a 90-day medication-change interval to 180 days, sponsor Representative Behning told the Senate Public Health Committee.
"This bill would actually just extend it to six months," Representative Behning said, describing his own experience with chronic pain and an intrathecal pump that reduced his need for frequent opioid patches and clinic visits.
Dr. Joshua Wellington, an interventional pain specialist with 21 years of practice who testified in support, said intrathecal drug delivery administers tiny doses directly into spinal fluid and can be 100 to 300 times more potent than oral doses. He said the therapy typically uses microdoses — often less than 1 milligram per day — and reduces systemic exposure that can lead to addiction, tolerance and cognitive side effects. "This will allow people just to live their lives with more freedom so that they can come to the doctor just twice a year versus three or four times a year," Wellington said.
Committee members praised the bill and recounted constituent outreach on access to care for chronic-pain patients. There were no questions that led to changes in the bill text during the hearing.
The committee voted to pass HB1200 by a voice roll call recorded as 12 ayes, 0 nays. The committee clerk announced a "Do pass 12 to 0" recommendation.
